|
Facebook
Twitter
Linkedin
|
HIMSS Analytics Honors 15 Hospitals with Stage 7 Award at HIMSS 2009
| Medical Conferences News - HIMSS 2009 |
HIMSS Analytics developed the EMR Adoption Model in 2005 as a methodology for evaluating the progress and impact of electronic medical record systems for hospitals in the HIMSS Analytics™ Database. Tracking their progress in completing eight stages (0-7), hospitals can review the implementation and utilization of information technology applications with the intent of reaching Stage 7, which represents an advanced patient record environment.
Stage 7 hospitals:
- Deliver patient care without the use of paper charts
- Are able to share patient information by sending secure standardized summary record transactions to other care providers
- Use their vast database of clinical information to drive improved care delivery performance, patient safety clinical decision support, and outcomes using business intelligence solutions
- Are best practice examples of how to implement sophisticated EMR environments that fully engage their clinicians
The validation process confirms that a hospital has reached Stage 7, which includes a site visit conducted by an executive from HIMSS Analytics and two, independent current, or former, chief information officers to ensure an unbiased evaluation of the Stage 7 environments. This team visits a representative hospital that has the same EMR applications and clinical utilization of those EMR applications running in all facilities.
About HIMSS Analytics
HIMSS Analytics is a wholly owned not-for-profit subsidiary of the Healthcare Information and Management Systems Society (HIMSS). The company collects and analyzes healthcare data related to IT processes and environments, products, IS department composition and costs, IS department management metrics, healthcare trends and purchase-related decisions. HIMSS Analytics delivers high quality data and analytical expertise to healthcare delivery organizations, healthcare IT companies, state governments, financial companies, pharmaceutical companies, and consulting firms.
Source: HIMSS











